Palvella Therapeutics, Inc. (PVLA) Operating cash flow 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.0MFY2025 · since FY2016: -$14.4M → -$25.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.0M | -130.7% |
| FY2024 | -$10.8M | +20.9% |
| FY2023 | -$13.7M | +77.1% |
| FY2022 | -$59.9M | -682.4% |
| FY2021 | -$7.7M | +83.3% |
| FY2020 | -$45.9M | +12.5% |
| FY2019 | -$52.5M | -4821.9% |
| FY2018 | -$1.1M | -102.1% |
| FY2017 | $49.8M | +445.8% |
| FY2016 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice